Journal: Frontiers in Immunology
Article Title: An optimized spectral flow cytometry pipeline for longitudinal blood leukocyte immunophenotyping reveals stable, individually distinct immune signatures
doi: 10.3389/fimmu.2026.1959895
Figure Lengend Snippet: Pre-analytical handling effects on leukocyte composition and two-tier normalization. Whole blood from healthy donors was processed under varying pre-analytical conditions (n = 3 replicates per condition) and immunophenotyped by flow cytometry; populations are expressed as a percentage of total leukocytes. (A–D) Mean leukocyte subset composition (stacked bars: neutrophils, monocytes/macrophages/dendritic cells, eosinophils, B cells, T cells) per condition, with the five-population Bray–Curtis PERMANOVA result above each panel: (A) refrigerated storage at 4°C for 1, 2 or 3 days (Day 1 fresh reference; samples were pooled then split from donor 1, 4, and 6); (B) cryopreservation in CryoStor CS10 or DMSO for 15 days versus fresh (samples were split from donor 4); (C) chemical fixation analyzed at Day 1 or Day 5 versus unfixed Day 1 (samples were split from donor 4); (D) one-week-stored versus freshly prepared antibody cocktail (samples were split from donor 4). Companion data of numerical mean values in . (E–H) Two sequential leukocyte count normalization tiers were compared against raw counts for longitudinal stability. Tier 1 rescaled within-sample (to CD45 + % [%CD45], or to cells/mL by counting beads [bead] or volume [vol]); Tier 2 added a CD-CHEX-anchored cross-batch correction to remove run-to-run drift (schemes detailed in ): (E) Lineage populations of CD-CHEX, including eight major lineage populations (as described in ), were assessed for count stability over time (y-axis, Bray–Curtis dissimilarity to the first timepoint per tier, x-axis, acquisition month; lower and flatter = more stable). Each line is one normalization scheme (color) for one held-out CD-CHEX lot (line style and point shape distinguish the two lots, CHEX 3268 and CHEX 5069), with raw counts (raw) shown in every facet as a common reference; facets are the three Tier families (%CD45, bead, vol). The dashed line marks a dissimilarity of 0.1 for reference. (F) Posterior contrasts of CD-CHEX lineage count stability for each scheme versus raw counts (model below). (G) Longitudinal stability of lineage and subpopulation counts from fresh blood of 10 donors (populations as in ). X-axis, visit in chronological order; y-axis, mean Bray–Curtis dissimilarity to the first visit across donors, with the shaded ribbon the standard error across donors; each line is one scheme (color), raw counts repeated in each facet as reference; facets are level (lineages, subpopulations) × Tier family. (H) Corresponding posterior contrasts versus raw counts. In (F, H) , Bray–Curtis dissimilarity to the reference timepoint was modelled by Beta regression (brms) with normalization scheme as a fixed effect and a random intercept per population group (CD-CHEX lot in F; donor in H). Points are the posterior median difference from raw counts (ΔBray–Curtis) and bars the 80% (thick) or 95% (thin) credible interval (CI); negative values indicate greater stability than raw. A scheme was classed as more stable (green) or less stable (orange) than raw when its 95% CI excluded zero, and equivalent (gray) when it included zero. P denotes the posterior probability that a scheme has lower temporal dissimilarity than raw (the proportion of posterior draws with ΔBray–Curtis < 0), such that P = 1.00 indicates every draw favored greater stability. All models converged well (Rˆ ≤ 1.01, no divergent transitions); model convergence and fit diagnostics are given in .
Article Snippet: CD-CHEX Plus stabilized human blood (213323, lots 32680071, 41550071, 50690071 and 53210071, Streck) was used as a biological-invariant control.
Techniques: Flow Cytometry, Stability, Counting